Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Savara Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SVRA
Nasdaq
2834
www.savarapharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Savara Inc.
Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041
- Jul 30th, 2026 6:05 am
Here's Why You Should Add Savara Stock to Your Portfolio Now
- Jul 22nd, 2026 7:21 am
Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors
- Jun 30th, 2026 5:30 am
What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline
- Jun 27th, 2026 9:34 am
Assessing Savara (SVRA) Valuation As Shares Cool After Strong Long Term Returns
- Jun 8th, 2026 11:13 am
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
- May 23rd, 2026 4:33 pm
Savara Inc. (SVRA) Reports Q1 Financial Results
- May 22nd, 2026 12:43 pm
US High Growth Tech Stocks To Watch
- Apr 27th, 2026 11:38 am
Assessing Savara (SVRA) Valuation After FDA Extends Priority Review For Molgramostim
- Apr 26th, 2026 11:03 am
High Growth Tech Stocks To Watch In The US March 2026
- Mar 26th, 2026 5:40 am
VR Adviser Adds Over 1 Million Savara Shares
- Mar 15th, 2026 8:59 am
Savara (SVRA) Is Down 8.0% After FDA Grants Priority Review To MOLBREEVI - What's Changed
- Mar 6th, 2026 3:12 am
Savara Highlights FDA Priority Review for Molbreevi as Aug. 22 PDUFA Date Nears
- Mar 1st, 2026 5:36 pm
Savara Eyes August PDUFA for MOLBREEVI as FDA BLA Filing Decision Nears, Execs Say at Summit
- Feb 15th, 2026 9:03 am
High Growth Tech Stocks To Watch In The US Market
- Feb 13th, 2026 4:38 am
Savara Insiders Added US$535.6k Of Stock To Their Holdings
- Feb 9th, 2026 4:42 am
A Look At Hercules Capital (HTGC) Valuation After The Expanded Savara Loan Agreement
- Jan 27th, 2026 9:34 pm
High Growth Tech Stocks To Watch In The US Market January 2026
- Jan 13th, 2026 4:38 am
With 37% stake, Savara Inc. (NASDAQ:SVRA) seems to have captured institutional investors' interest
- Jan 11th, 2026 7:01 am
3 High Growth Tech Stocks To Watch In The US Market
- Dec 15th, 2025 4:38 am
Scroll